Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03225313
Other study ID # 722014
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 10, 2017
Est. completion date December 30, 2017

Study information

Verified date March 2021
Source Theodor Bilharz Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Randomized double blinded controlled clinical trial will be done with a total number of 75 patients will be divided into 3 groups. To compare between Ultra-sound guided rectus sheath block VS Field block infiltration in providing a good analgesia for patients undergoing midline hernia repair to detect which one is superior.


Description:

75 patients undergoing midline hernia repair under general anesthesia will be recruited and will be randomly allocated using closed envelope technique as follows: Control group, Local infilteration (Field block infilteration) group, Ultra sound Guided Rectus sheath block group. General anesthesia will be standardized for all patients with : 2 µg kg-1 fentanyl and 2 mg kg-1 propofol. Neuromuscular blockade will be achieved with 0.5 mg kg-1 atracurium followed by tracheal intubation. Muscle relaxation will be maintained by 0.1mg / kg / 30 minute of Atracrurium. Anesthesia will be maintained by sevoflurane. Mechanical ventilation will be adjusted with fresh gas flow oxygen in air 30-50% at a rate of 1 L min-1to maintain end-tidal carbon dioxide of 35-40 mm Hg and Spo2 greater than 94%. BIS values will be maintained between 40 and 60. All surgical procedures will be done in the range between 10 am and 1 pm and by the same surgical team. 1. Control group : will receive field block using 0.3 ml/kg of normal saline at site of the hernia plus ultra- sound guided rectus sheath injection using 0.3 ml / kg of normal saline. 2. Field block group: will receive 0.3 ml / kg of 0.5% bupivicaine subcutaneously surrounding the site of the hernia following the induction of anesthesia and ultra-sound guided rectus sheath block with 0.3 ml / kg of normal saline. 3. Ultrasound guided rectus sheath block : Under sterile conditions a 21/22 G , 50- 100 milli meter length echogenic needle guided by the ultrasound into rectus sheath at the level of the umbilicus , using an - in plane technique. After -ve aspiration 0.3 ml/ kg of 0.5 % bupivicaine will be deposited on each side and the spread of local anesthesia will be observed by ultrasound plus 0.3 ml/kg of normal saline subcutaneously at the site of the hernia. All solutions used will be prepared by a colleague who will not participate into the study.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date December 30, 2017
Est. primary completion date December 30, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: 1. Elective midline hernia repair surgery. 2. Age: adult patients between 18 - 60 years old. 3. Gender: Both male and female. 4. ASA Class: I & II. Exclusion Criteria: 1. Refusal of patient. 2. Pregnancy and lactation. 3. Fever or sepsis. 4. Patients ASA III or IV. 5. Addicts and drug abusers. 6. Patients taking corticosteroids or any cardio - active drugs. 7. Local infection at site of the injection. 8. Allergy to any of the study medications.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Bupivacaine Hydrochloride 0.5% Injection Solution_#4
ultra sound guided injection into the rectus sheath
Normal Saline Flush, 0.9% Injectable Solution_#5
injected into rectus sheath using ultrasound & locally surrounding the hernia
Bupivacaine Hydrochloride 0.5% Injection Solution_#4
locally surrounding the hernia

Locations

Country Name City State
Egypt Theodor Bilharz Research Institute Giza

Sponsors (1)

Lead Sponsor Collaborator
Theodor Bilharz Research Institute

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Immediate Postoperative Pain Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.
evaluation of postoperative pain in patients immediately after the procedure.
Primary Postoperative Pain at 2 Hours After Procedure. Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.
evaluation of postoperative pain in patients at 2 hours after procedure.
Primary Postoperative Pain at 6 Hours After Procedure. Evaluation of the intensity of postoperative pain using Visual Analogue Scale (VAS) for pain: 0- 10 Scale; 0 the lowest pain score, 10 the highest pain scale.
0 score: Better pain control achieved. 10 score: Worst pain control achieved. 3 score: Controllable pain control achieved.
Evaluation of postoperative pain in patients at 6 hours after procedure.
Secondary Change in the Level of Serum Cortisol. Measurement of serum cortisol level (nmol/ liter) using the ELISA technique after 1 hour of the start of the surgery. Measurement of serum cortisol level (nmol/ liter) using the ELISA technique after 1 hour of the start of the surgery.
Secondary Measurement of Serum Adrenaline Levels (ng/ml) Using ELISA Technique. Measurement of serum adrenaline levels (ng/ml) 1 hour after the start of the surgery using ELISA technique. 1 hour after the start of the surgery using ELISA technique.
Secondary Measurement of Serum Noradrenaline Levels (ng/ml) Using ELISA Technique. Measurement of serum noradrenaline levels (ng/ml) 1 hour after the start of the surgery using ELISA technique. 1 hour after the start of the surgery
Secondary Measurement of Serum Cortisol Level (Nmol/ Liter) Using ELISA Technique. Measurement of serum cortisol level (nmol/ liter) using ELISA technique 30 minutes before the start of the surgery 30 minutes before the start of the surgery
Secondary Measurement of Serum Adrenaline Level (ng/ml) Using ELISA Technique. Measurement of serum adrenaline level (ng/ml) using ELISA technique 30 minutes before the start of the surgery. 30 minutes before the start of the surgery
Secondary Measurement of Serum Noradrenaline Levels (ng/ml) Using ELISA Technique. Measurement of serum noradrenaline levels (ng/ml) using ELISA technique 30 minutes before the start of the surgery. 30 minutes before the start of the surgery.
See also
  Status Clinical Trial Phase
Completed NCT05480111 - The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy Phase 4
Completed NCT06129305 - Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
Completed NCT04401826 - Micro-surgical Treatment of Gummy Smile N/A
Recruiting NCT04020133 - the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction. N/A
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT03652103 - Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy Phase 4
Completed NCT03546738 - Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery N/A
Withdrawn NCT03528343 - Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy Phase 1/Phase 2
Terminated NCT03261193 - ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain Phase 3
Completed NCT02525133 - Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty Phase 3
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Enrolling by invitation NCT05316168 - Post Operative Pain Management for ACL Reconstruction Phase 3
Recruiting NCT04130464 - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management Phase 4
Enrolling by invitation NCT04574791 - Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty N/A
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Completed NCT04073069 - Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults Phase 4
Recruiting NCT05351229 - Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery Phase 4
Enrolling by invitation NCT05543109 - Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04919317 - Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty Phase 2